
Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower...
You can purchase shares of DIAGNAMED HLDGS CORP by Diagnamed Holdings Corp. (OTCQB:DGNMF) through any online brokerage.
There are no as such competitors for DIAGNAMED HLDGS CORP by Diagnamed Holdings Corp..
There is no analysis for DIAGNAMED HLDGS CORP by Diagnamed Holdings Corp. to provide a consensus price target.
The stock price for DIAGNAMED HLDGS CORP by Diagnamed Holdings Corp. (OTCQB: DGNMF) is $0.018 last updated November 13, 2026 at 10:07 AM EST.
There are no upcoming dividends for DIAGNAMED HLDGS CORP by Diagnamed Holdings Corp..
DIAGNAMED HLDGS CORP by Diagnamed Holdings Corp. does not have any upcoming earnings scheduled.
There is no upcoming split for DIAGNAMED HLDGS CORP by Diagnamed Holdings Corp..
DIAGNAMED HLDGS CORP by Diagnamed Holdings Corp. is in the Healthcare sector and Health Information Services industry. They are listed on the OTCQB.